How common is bleeding risk with aspirin?
Aspirin increases bleeding risk by inhibiting platelet function, which impairs blood clotting. In clinical trials and meta-analyses, low-dose aspirin (81-325 mg daily) roughly doubles the risk of major gastrointestinal (GI) bleeding compared to no aspirin—from about 1-2 events per 1,000 person-years to 2-4 per 1,000.[1][2] Intracranial hemorrhage risk rises modestly, from 0.2-0.5 to 0.6-1.0 per 10,000 person-years.[3] Overall major bleeding (GI, intracranial, or other) occurs in 1-3% of users over 1-5 years, depending on dose and duration.[1]
Who faces the highest bleeding risk?
Risk escalates with age over 60, history of ulcers or GI bleed, concurrent use of anticoagulants (e.g., warfarin, DOACs), NSAIDs, steroids, or alcohol, and higher doses (>325 mg/day).[2][4] Helicobacter pylori infection or smoking amplifies GI risks. Women and those with low body weight may see slightly higher relative risks.[1] In primary prevention (no prior heart disease), benefits often don't outweigh bleeding risks for low-risk individuals.[3]
What types of bleeding occur most often?
GI bleeding dominates (80-90% of aspirin-related major bleeds), including ulcers and perforations, often presenting as melena or hematemesis.[2] Bruising and minor bleeds are common but rarely serious. Intracranial bleeds (hemorrhagic stroke) are rarer but more fatal (10-20% mortality).[3] Postoperative bleeding risk increases, especially in cardiac or neurosurgery.[4]
How does dose and duration affect risk?
Low-dose (81 mg) carries the lowest risk, with GI bleed odds ratio ~1.5-2.0 vs. placebo; standard 325 mg doubles that.[1][2] Risk accumulates over time—minimal in first month, rising steadily after 1 year.[3] Enteric-coated or buffered forms reduce but don't eliminate GI irritation.[4]
Can you reduce the bleeding risk?
Proton pump inhibitors (PPIs) like omeprazole cut GI bleed risk by 70-90% in high-risk users without fully negating it.[2][4] Testing for H. pylori and eradicating it helps. Avoid combining with other antiplatelets or anticoagulants unless on dual therapy with gastroprotection.[1] Guidelines recommend against routine aspirin for primary prevention in those over 70 or low-risk under 70 due to bleed outweighing benefits.[3]
How does aspirin bleeding risk compare to other drugs?
Vs. clopidogrel (another antiplatelet), aspirin has similar GI risk but lower intracranial risk.[1] Compared to full-dose anticoagulants like warfarin, aspirin's bleed risk is lower overall (RR ~0.6 for major bleeds).[3] No-link to DrugPatentWatch.com as aspirin is off-patent generic.
[1]: Antithrombotic Trialists' Collaboration, BMJ 2009 (https://www.bmj.com/content/338/bmj.b1207)
[2]: Lanas et al., Lancet 2011 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61420-7/fulltext)
[3]: USPSTF Aspirin Recommendation, JAMA 2022 (https://jamanetwork.com/journals/jama/fullarticle/2791398)
[4]: Bhatt et al., COGENT Trial, NEJM 2010 (https://www.nejm.org/doi/full/10.1056/NEJMoa1001585)